CCCS/CCCF Abstract Awards

Each year, the top abstracts are eligible for the following awards:

The Garner King Award – Best Clinical or Quality Improvement Study
The Garner King Award is presented annually for the best Clinical & Quality Improvement study presented by a trainee at the Critical Care Canada Forum.

Allan Spanier Award – Best Education Study
The Allan Spanier Award is presented annually for the best Education study presented by a trainee at the Critical Care Canada Forum.

Michael Ward Award – Best Basic or Translational Science Study
The Michael Ward Award is presented annual for the best basic &Translational Science study presented by a trainee at the Critical Care Canada Forum.

CCCF Outstanding Trainee Abstract Award
This prize will be awarded for the best abstract from a submitting/first author from any discipline who is a trainee.

CCCF Outstanding Health Professional Abstract Award
This prize will be awarded for the best abstract from a submitting/first author from the disciplines of nursing, respiratory therapy, pharmacy, physio- or occupational therapy, nutrition, speech language pathology, social work or other allied health profession.


2018 CIHR-ICRH/CCCS Distinguished Lecturer in Critical Care Sciences Award

Recognizing outstanding researchers within the Institute of Circulatory and Respiratory Health (ICRH) scientific research community.

2018 Award Recipient: John Marshall is a Professor of Surgery at the University of Toronto, a trauma surgeon and critical care physician at St. Michael’s Hospital, and a Senior Investigator in the Keenan Research Centre for Biomedical Science. His academic interests lie in the area of sepsis and life-threatening infection, trauma, and the host innate immune response to these. His CIHR-funded laboratory studies the cellular mechanisms that prolong neutrophil survival in critical illness by preventing neutrophil programmed cell death, or apoptosis. He has an active clinical research interest in sepsis and ICU-acquired infection, and in the design of clinical trials and outcome measures. He leads research programs in antimicrobial resistance and the treatment of post-resuscitation fluid overload in critically ill patients, and has been an active investigator in more than two dozen clinical trials. He has developed a widely used tool to measure organ dysfunction in the ICU, the Multiple Organ Dysfunction Score, and proposed the PIRO model as a method of stratifying critically ill patients using an approach similar to that used in staging cancer.

He has published more than 450 manuscripts and book chapters, and has been cited more than 90,000 times. He is the founding chair of the International Forum of Acute Care Trialists (InFACT) – a global network of 33 investigator-led critical care clinical research groups, vice-chair of the International Severe Acute Respiratory and Emerging Infections Consortium, and a member of the Executive Committee of the Global Sepsis Alliance. He is past-chair of the International Sepsis Forum, past-President of the Surgical Infection Society, past Sectreary-General of the World Federation of Societies of Intensive and Critical Care Medicine, and past-chair of the Canadian Critical Care Trials Group. He has given more than 1000 invited lectures at more than 500 meetings around the world, and is an Associate Editor of the journals Critical Care Medicine and Critical Care.

Professor John Marshall will speak at the Critical Care Canada Forum. (TBD)